Evidence map›Paper›PMID 32874129›Full record

ArticleCancer cell international2020

Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis.

Qingyang Meng, Xiangjun Wang, Tongqing Xue, Qiangfang Zhao, Wei Wang, Kun Zhao

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Functional, Pharmacogenomic, and Immune Landscapes of Long Non-Coding RNAs in Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hepatic Expression of the NaInternational journal of molecular sciences · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Qingyang Meng *Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiangjun Wang *Department of General Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
Tongqing XueDepartment of Oncology, Huaian Hospital of Huaian City, No.161 Zhenhuailou East Road, Huai'an, 223200 Jiangsu China.
Qiangfang ZhaoDepartment of Oncology, Huaian Hospital of Huaian City, No.161 Zhenhuailou East Road, Huai'an, 223200 Jiangsu China.
Wei WangDepartment of Oncology, Huaian Hospital of Huaian City, No.161 Zhenhuailou East Road, Huai'an, 223200 Jiangsu China.
Kun ZhaoDepartment of Oncology, Huaian Hospital of Huaian City, No.161 Zhenhuailou East Road, Huai'an, 223200 Jiangsu China.ORCID 0000-0002-7521-341X
Huaian First People’s Hospital · CNSun Yat-sen University · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong non-coding RNAs (lncRNAs) play a vital role in the genesis and development of human cancer. LncRNA MIR99AHG has been reported to be upregulated in acute myeloid leukemia (AML); however, its function in gastric cancer (GC) is still not clear. Here we were aiming to screen the prognostic lncRNA candidates and to explore the function of MIR99AHG in GC.

methodsWe have preliminarily screened some candidate lncRNA biomarkers in GC tissues through analyzing microarray datasets. The expression level of MIR99AHG in GC cell lines and tissues was monitored via qPCR. Survival analysis was performed with the patients of our hospital and TCGA database cases. CCK-8 assay, trans-well assay and flow cytometry were performed to determine cell proliferation, invasion, migration and apoptosis. Meanwhile, a target of MIR99AHG was predicted and identified by luciferase reporter gene detection experiments.

resultsMIR99AHG was strongly up-regulated in human GC and contributed to cancer progression. Kaplan-Meier analysis revealed that up-regulating MIR99AHG expression was positively correlated with unfavorable overall survival (P < 0.01) of patients from our hospital and TCGA database. Knockdown of MIR99AHG expression inhibited cell proliferation, invasion, migration and promoted cell apoptosis. Moreover, MIR99AHG worked as an oncogenic gene though competing for endogenous RNA (ceRNA) of miR-577.

conclusionsOur findings suggested that MIR99AHG contributes to malignant phenotypes of GC and may become a promising therapeutic target.

Indexed as

ceRNAFOXP1Gastric cancerlncRNAmiR-577MIR99AHGmiRNA

Identifiers

PMID32874129
PMCPMC7457246
OpenAlexW3080761215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.